膜铁转运蛋白在肾性贫血中的研究进展

doi:10.3969/j.issn.1671-4091.2021.04.013

摘要/Abstract

摘要： 【摘要】膜铁转运蛋白(ferroportin,Fpn)是目前唯一的铁转出蛋白，它在控制饮食中铁的吸收，巨噬细胞和其他细胞中铁的排出中起着重要作用。铁是机体不可缺少的物质，参与血红蛋白合成。一旦Fpn的表达发生障碍，必定会导致铁代谢紊乱，从而引起多种疾病的发生发展。当然也可引起红细胞生成减少，甚至引起和加重慢性肾脏病(chronic kidney disease，CKD)贫血。因此，Fpn 在机体铁代谢中发挥着重要作用。本文就Fpn在肾性贫血中的研究进展作一综述。

关键词: 膜铁转运蛋白, 慢性肾脏病, 贫血, 铁代谢

Abstract: 【Abstract】Ferroportin (Fpn) is currently the unique iron export transfer protein, playing an important role in controlling the absorption of iron in diet and the excretion of iron from macrophages and other cells. Iron is an indispensable element in the body, participating in hemoglobin synthesis. If the expression of Fpn is disturbed, iron metabolism disorder and many related diseases will inevitably occur, red blood cell production is decreased, and chronic kidney disease (CKD) anemia is aggravated. This article reviews the research progress in Fpn, an important protein in the regulation of iron metabolism, in renal anemia.

Key words: Ferroportin, Chronic kidney disease, Anemia, Iron metabolism

中图分类号:

R692

席悦, 杜玄一. 膜铁转运蛋白在肾性贫血中的研究进展[J]. 中国血液净化, 2021, 20(04): 273-276.

参考文献

[1]Taniguchi R, Kato HE, Font J, et al.Outward- and inward-facing structures of a putative bacterial transition-metal transporter with homology to ferroportin. [J].Nat Commun, 2015, 6:8545- [2]Bonaccorsi di Patti MC, Cutone A, Polticelli F, et al.The ferroportin ceruloplasmin system and the mammalian iron homeostasis machine: regulatory pathways and the role of lactoferrin[J].Biometals, 2018, 31(3):399-414 [3]Donovan A, Lima CA, Pinkus JL, et al.The iron exporter ferroportinSlc40a1 is essential for iron homeostasis[J].Cell Metab, 2005, 1(3):191-200 [4]Hawula ZJ, Wallace DF, Subramaniam VN, et al.Therapeutic advances in regulating the hepcidin/ferroportin axis. [J].Pharmaceuticals (Basel), 2019, 12:170- [5]Zhang DL, Rouault TA.How does hepcidin hinder ferroportin activity? [J].Blood, 2018, 131(8):840-842 [6]Zhang DL, Wu J, Shah BN, et al.Erythrocytic ferroportin reduces intracellular iron accumulation,hemolysis,and malaria risk[J].Science, 2018, 359(6383):1520-1523 [7]Zhang DL, Ghosh MC, Ollivierre H, et al.Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress[J].Blood, 2018, 132(19):2078- [8]Qian Y, Yin C, Chen Y, et al.Estrogen contributes to regulating iron metabolism through governing ferroportin signaling via an estrogen response element[J].Cell Signal, 2015, 27(5):934-942 [9]Pietrangelo A.Ferroportin disease: pathogenesis,diagnosis and treatment[J].Haematologica, 2017, 102(12):1972-1984 [10]Wang CY, Babitt JL.Hepcidin regulation in the anemia of inflammation[J].Curr Opin Hematol, 2016, 23(3):189- [11]De Domenico I, Ward DM, di Patti MC, et al.Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin[J].EMBO J, 2007, 26(12):2823-2831 [12]Harris ZL.Aceruloplasminemia[J].J Neurol Sci, 2003, 207(1-2):108-109 [13]Fuqua BK, Lu Y, Darshan D, et al.The multicopper ferroxidase hephaestin enhances intestinal iron absorption in mice. [J].PLoS ONE, 2014, (9):e98792- [14]Fuqua BK, Lu Y, Frazer DM, et al.Severe Iron metabolism defects in mice with double knockout of the multicopper ferroxidases hephaestin and ceruloplasmin. [J].Cell Mol Gastroenterol Hepatol, 2018, (6):405-427 [15]Yanatori I, Kishi F.DMT1 and iron transport. [J].Free Radic Biol Med, 2019, 133:55-63 [16]Yanga QY, Liua L, Zhang SP,. The cardinal roles of ferroportin and its partners in controlling cellular iron in and out[J].Life Sciences, 2020, (258):118135- [17]Yanatori I, Richardson DR, Imada K, Kishi F.Iron Export through the Transporter Ferroportin 1 Is Modulated by the Iron Chaperone PCBP2[J].J Biol Chem, 2016, 291(33):17303-17318 [18]Wang L, Liu X, You LH, et al.Hepcidin and iron regulatory proteins coordinately regulate ferroportin 1 expression in the brain of mice[J].J Cell Physiol, 2019, 234(5):7600-7607 [19]Zhang DL, Hughes RM, Ollivierre-Wilson H, Ghosh MC, Rouault TA.A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression[J].Cell Metab, 2009, 9(5):461-473 [20]Ludwiczek S, Aigner E, Theurl I, Weiss G.Cytokine-mediated regulation of iron transport in human monocytic cells[J].Blood, 2003, 101(10):4148-4154 [21]Urrutia P, Aguirre P, Esparza A, et al.Inflammation alters the expression of DMT1,FPN1 and hepcidin,and it causes iron accumulation in central nervous system cells[J].J Neurochem, 2013, 126(4):541-549 [22]di Patti MC, Persichini T, Mazzone V, Polticelli F, Colasanti M, Musci G.Interleukin-1beta up-regulates iron efflux in rat C6 glioma cells through modulation of ceruloplasmin and ferroportin-1 synthesis[J].Neurosci Lett, 2004, 363(2):182-186 [23]Persichini T, Maio N, di Patti MC, et al.Interleukin-1β induces ceruloplasmin and ferroportin-1 gene expression via MAP kinases and CEBPβ,AP-1,and NF-κB activation[J].Neurosci Lett, 2010, 484(2):133-138 [24]Ueda N, Takasawa K.Impact of Inflammation on Ferritin,Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease[J].Nutrients, 2018, 10(9):1173- [25]Begum S, Latundedada GO.Anemia of Inflammation with An Emphasis on Chronic Kidney Disease[J].Nutrients, 2019, 11(10):2424- [26]Taylor M, Qu A, Anderson ER, et al.Hypoxia-inducible factor-2α mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice[J].Gastroenterology, 2011, 140(7):2044-2055 [27]Schwartz AJ, Das NK, Ramakrishnan SK, et al.Hepatic hepcidinintestinal HIF-2alpha axis maintains iron absorption during iron deficiency and overload[J].J Clin Invest, 2019, 129(1):336-348 [28]Wilkinson N, Pantopoulos K.IRP1 regulates erythropoiesis and systemic iron homeostasis by controlling HIF2αmRNA translation[J].Blood, 2013, 122(9):1658-1668 [29]Chen N, Hao C, Peng X, et al.Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis[J].N Engl J Med, 2019, 381(11):1001-1010 [30]Chen N, Hao C, Liu BC, et al.Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis[J].N Engl J Med, 2019, 381(11):1011-1022